Difficulty: Medium
Average Score: 79%
Practice
The most important receptor involved in cytotoxic drug induced vomiting is
Correct answer
B
Rationale
In the context of cytotoxic drug-induced vomiting, the most important receptor involved is the Serotonin 5-HTÔéâ receptor, making option B the correct answer. Serotonin 5-HTÔéâ receptors are located peripherally on vagal afferents in the gastrointestinal tract and centrally in the chemoreceptor trigger zone. When activated by cytotoxic drugs, these receptors trigger afferent signals to the vomiting center in the brain, leading to the sensation of nausea and vomiting.
Option A, Histamine HÔéü receptor, is involved in allergic reactions and not specifically linked to cytotoxic drug-induced vomiting. Option C, Dopamine D2 receptor, is more relevant in the context of antiemetic drugs targeting chemotherapy-induced vomiting. Option D, Opioid ╬╝ receptor, plays a role in pain modulation rather than vomiting.
Educationally, understanding the specific receptors involved in different types of vomiting can aid healthcare professionals in selecting the most appropriate antiemetic therapy for their patients, based on the underlying cause of nausea and vomiting. This knowledge is crucial in providing effective symptom management and improving patient outcomes during cancer treatment or other scenarios involving cytotoxic drug administration.
Option A, Histamine HÔéü receptor, is involved in allergic reactions and not specifically linked to cytotoxic drug-induced vomiting. Option C, Dopamine D2 receptor, is more relevant in the context of antiemetic drugs targeting chemotherapy-induced vomiting. Option D, Opioid ╬╝ receptor, plays a role in pain modulation rather than vomiting.
Educationally, understanding the specific receptors involved in different types of vomiting can aid healthcare professionals in selecting the most appropriate antiemetic therapy for their patients, based on the underlying cause of nausea and vomiting. This knowledge is crucial in providing effective symptom management and improving patient outcomes during cancer treatment or other scenarios involving cytotoxic drug administration.